Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance

摘要

DNA fragments released from cancer cells into the blood can be used to generate molecular profiles of tumors. Non-invasive 'liquid biopsies' can be used to monitor minimal residual disease and detect the emergence of drug resistance.